GenVec (GNVC)
GenVec Net Income: -3.194M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
GNVC Net Income Rankings
| Overall | 17th percentile | 3724 of 4521 |
| Sector | 35th percentile | 329 of 513 in Healthcare |
| Industry | 61st percentile | 62 of 160 in Biotechnology |
GNVC Net Income Range, Past 5 Years
| Minimum | -6.839M | Sep 2008 |
| Maximum | -1.004M | Dec 2010 |
| Average | -4.002M |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line.
Learn More
You may also be interested in these GNVC related companies
GNVC News
GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
May 03, 8:30AM PR Newswire
May 03, 8:30AM PR Newswire
Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against GenVec, Inc.
Jan 10, 3:52PM Business Wire
Jan 10, 3:52PM Business Wire
GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011
Nov 02, 8:40AM PR Newswire
Nov 02, 8:40AM PR Newswire
$GNVC http://stks.co/Axr trying to sneak out here. Sneak sneak sneak.
about 260 days ago by retailtrader
about 260 days ago by retailtrader
In LiveCharts today, we analyzed the charts on $MOTR $UCO $DF $AAPL $SPY $LLNW KKD $GNVC $HSOL and REMX http://stk.ly/mpKIaS
about 341 days ago by SharePlanner
about 341 days ago by SharePlanner
$LPX Buying trigger : $8.04 Profit: 1.8% $GNVC Buying Trigger: $ 3.11 Profit : 4.5% $LAVA Buying Trigger $7.90 Profit: 2.27%
about 342 days ago by Trade4Me
about 342 days ago by Trade4Me
$GNVC Buying Trigger: $ 3.11 Volume change: 137% Earnings Growth: 56% Revenue Growth 82%
about 342 days ago by Trade4Me
about 342 days ago by Trade4Me
Watch List : $LAVA Buying Trigger $ 7.90 $BJRI Buying Trigger: $ 48.31 $GNVC Buying Trigger: $ 3.11
about 343 days ago by Trade4Me
about 343 days ago by Trade4Me
RT @adamfeuerstein Other bio-shells available for reverse mergers -- $TELK, $GNVC (h/t @LTbioinvestor)
about 351 days ago by chicagosean
about 351 days ago by chicagosean
$GNVC GenVec Technology Used To Restore Lost Balance Function http://stk.ly/haJmMo
about 415 days ago by mike_peace
about 415 days ago by mike_peace
$gnvc something happening, nice volume and breakout on a weak tape. risky tho
about 495 days ago by mike_peace
about 495 days ago by mike_peace
nibbled at some $GNVC today....because ya never know when a spike can occurr
about 497 days ago by beachlife
about 497 days ago by beachlife
my watchlist for week 17-21 January 2011 http://stk.ly/hPSzN9 $SOL $PTIE $ENMD $GNVC $X $MOTR $FORM
about 499 days ago by mike_peace
about 499 days ago by mike_peace
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GNVC | 2.475 | -0.03 | -1.00% | 32.40M |
| ING | 6.05 | +0.09 | +1.51% | 22.54B |
| INFY | 43.44 | +0.98 | +2.31% | 24.26B |
| INFU | 1.82 | -0.08 | -4.21% | 40.53M |
| INFN | 6.615 | +0.20 | +3.04% | 702.67M |
| INFI | 13.00 | +0.27 | +2.12% | 340.65M |
| INFA | 43.23 | +0.66 | +1.55% | 4.571B |
| INCY | 22.38 | -0.03 | -0.13% | 2.853B |
| INAP | 7.17 | +0.04 | +0.56% | 375.96M |
| IN | 5.99 | +0.44 | +7.93% | 332.06M |
